- Gastrointestinal Carcinoid Tumor
-
Sun JM, Jung HC
- KMID: 1113318
- Korean J Gastroenterol.
- 2004 Aug;44(2):59-65.
Carcinoid tumors originate from the neuroendocrine cells throughout the body and occur most frequently (74%) in the gastrointestinal tract. The clinical course is often indolent but can also be aggressive... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Primary Intestinal T-Cell Lymphoma Involving Entire Gastrointestinal Tract: Esophagus to Rectum
-
Ahn MJ, Park YW, Han D, Choi JH, Shin SJ, Yoon BC, Choi HS, Lee YY, Jung TJ, Choi IY, Park MH, Kim IS
- KMID: 759526
- Korean J Intern Med.
- 2000 Dec;15(3):245-249.
Primary intestinal T-cell lymphoma is a rare disease entity, which is approximately 10% to 25% of intestinal lymphomas, and most of the lymphomas occur in the small intestine. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib
-
Jang BH, Kim BW, Lim KJ, Kim BG, Park SM, Kim JS, Ji JS, Choi H
- KMID: 2373239
- Korean J Gastroenterol.
- 2015 Jun;65(6):366-369.
- doi: 10.4166/kjg.2015.65.6.366
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Plasma Tumor M2-Pyruvate Kinase in the Diagnosis of Gastrointestinal Cancer
-
Kim CW, Kim JI, Park SH, Han JY, Kim JK, Chung KW, Sun HS
- KMID: 1112189
- Korean J Gastroenterol.
- 2003 Nov;42(5):387-393.
BACKGROUND/AIMS: Pyruvate kinase (PK) is a key enzyme of glycolysis. Different isoforms of this enzyme are tissue-specifically expressed (M2-PK, M1-PK, R-PK, L-PK). The concentration of the dimeric M2-PK is... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Metastatic Tumors to the Ovaries
-
Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS
- KMID: 1794416
- J Korean Med Sci.
- 2009 Feb;24(1):114-119.
- doi: 10.3346/jkms.2009.24.1.114
Approximately 5-30% of the ovarian cancers are metastatic malignancies. The prevalence of metastatic ovarian tumors varies with the incidence rates and spread patterns of primary malignancies. We evaluated the prevalence,... -
- CITED
-
- Close
- SHARE
-
- Close
